文献速递血管炎

巨细胞动脉炎中的主动脉疾病

Aortic disease in giant cell arteritis.
PubMed 文献 · Semin Arthritis Rheum · 2025-02-23

本文综述巨细胞动脉炎(GCA)中主动脉疾病的影像学检出、自然病程与治疗现状。GCA起病时高达70%患者有主动脉炎影像学证据,约15%已存在主动脉扩张;GCA患者胸主动脉瘤风险估计高达一般人群的17倍,随访10年时高达1/3患者发生主动脉瘤。慢性隐匿性主动脉炎可能对现有治疗抵抗,夹层或破裂罕见但危及生命。

要点

  • GCA起病时高达70%患者有主动脉炎影像学证据,约15%已存在主动脉扩张。
  • GCA患者胸主动脉瘤风险估计高达一般人群的17倍,随访10年时高达1/3发生主动脉瘤。
  • 慢性隐匿性主动脉炎可能对现有治疗抵抗,持续数年并导致主动脉扩张进展。

核心结论

  • GCA中主动脉炎常临床隐匿,但是主动脉扩张进展和动脉瘤形成的危险因素。
  • 慢性隐匿性主动脉炎可能对现有治疗抵抗,持续数年并促进主动脉扩张进展。
  • GCA相关主动脉疾病的罕见但危及生命的并发症是夹层或破裂。

研究设计与样本

  • 本文为综述,总结GCA中主动脉疾病的影像学诊断、自然病程、结局与管理及发病机制研究进展。

主要发现

  • GCA起病时高达70%患者有主动脉炎影像学证据,约15%已存在主动脉扩张。
  • GCA中主动脉炎一般通过CT血管成像、MR血管成像或FDG-PET等影像学检查诊断,偶经动脉瘤修复术后主动脉切除标本的组织病理学诊断。
  • GCA患者胸主动脉瘤风险估计高达一般人群的17倍,随访10年时高达1/3患者发生主动脉瘤。
  • 与GCA相比,大动脉炎中的主动脉炎可导致主动脉扩张或狭窄,尤其位于胸降主动脉和腹主动脉。
  • 慢性隐匿性主动脉炎可能对现有治疗抵抗,持续数年并促进主动脉扩张进展;夹层或破裂是GCA相关主动脉疾病罕见但危及生命的并发症。

临床怎么用

  • 观察性研究正在为炎症性主动脉瘤的结局和管理提供信息。
  • 对主动脉组织的转录组学和分子学研究正在提供关于疾病发病机制的重要信息。
  • 对疾病病理生理学的进一步理解正在促进非糖皮质激素靶向治疗的开发。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The increasing use of non-invasive vascular imaging has allowed for improved detection of aortic disease in patients with vasculitis. Indeed, up to 70 % of patients have radiographic evidence of aortitis at GCA onset and aortic dilatation is already identified in about 15 %. Aortic inflammation is generally diagnosed by imaging studies such as CT angiography, MR angiography or FDG-PET, and occasionally by histopathology following resection of the aorta for aneurysm repair. Aortic inflammation may be clinically silent but is a risk factor for progressive aortic dilatation and aneurysm formation in GCA. By comparison, aortitis in Takayasu arteritis may lead to aortic dilatation or stenosis, particularly in the descending thoracic and abdominal aorta. The risk of thoracic aortic aneurysm in patients with GCA has been estimated to be up to 17-fold higher than that of the general population, with up to 1/3 of patients developing aortic aneurysm at 10 years of follow-up. Moreover, chronic smoldering aortitis may be refractory to current therapy, lasts for several years and contributes to progressive aortic dilatation. A rare but life-threatening complication of GCA-associated aortic disease is dissection or rupture. Observational studies are informing outcomes and management of inflammatory aortic aneurysms, while transcriptomic and molecular studies on aortic tissue are yielding important information regarding disease pathogenesis. These endeavors are critical to reducing the excess mortality related to aortic disease in GCA. Also, improved understanding of the pathophysiology of the disease is allowing the development of non-glucocorticoid targeted therapies.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Warrington KJ. Aortic disease in giant cell arteritis. Semin Arthritis Rheum. 2025. PMID: 40021438. doi:10.1016/j.semarthrit.2025.152677

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。